Cancer neoepitopes
US11421016B2 · kind B2 · utility
4Cited by
3References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 25, 2016 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | Nov 16, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Contemplated compositions and methods are directed to cancer neoepitopes and uses of such neoepitopes, especially to generate synthetic antibodies against neoepitopes that may then be employed in the manufacture of a therapeutic agent. Preferred therapeutic agents will comprise a synthetic antibody against a neoepitope, and most preferably in combination with a cellular or non-cellular component for use as a diagnostic or therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.